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Abstract 
Background: Indonesia introduced single screening and treatment (SST) of pregnant women for the control of 
malaria in pregnancy in 2012. Under this policy pregnant women are screened for malaria at their first antenatal clinic 
(ANC) visit and on subsequent visits are tested for malaria only if symptomatic. The implementation of this policy 
in two districts of Indonesia was evaluated. Cross sectional survey structured observations of the ANC visit and exit 
interviews with pregnant women were conducted to assess health provider compliance with SST guidelines. Systems 
effectiveness analysis was performed on components of the strategy. Multiple logistic regression was used to test for 
predictors of women being screened at their first ANC visit.
Results: A total of 865 and 895 ANC visits in Mimika and West Sumba across seven and ten health facilities (plus man-
aged health posts) respectively, were included in the study. Adherence to malaria screening at first ANC visit among 
pregnant women was 51.4% (95% CI 11.9, 89.2) in health facilities in Mimika (94.8% in health centres) and 24.8% (95% 
CI 10.3, 48.9) in West Sumba (60.0% in health centres). Reported fever was low amongst women presenting for their 
second and above ANC visit (2.8% in Mimika and 3.5% in West Sumba) with 89.5% and 46.2% of these women tested 
for malaria in Mimka and West Sumba, respectively. Cumulative systems effectiveness for SST on first visit to ANC was 
7.6% for Mimika and 0.1% for West Sumba; and for second or above visits to ANC was 0.7% in Mimika and 0% in West 
Sumba. Being screened on a 1st visit to ANC was associated with level of health facility in both sites.
Conclusion: Cumulative systems effectiveness of the SST strategy was poor in both sites. Both elements of the SST 
strategy, screening on first visit and passive case detection on second and above visits, was driven by the difference 
in implementation of malaria testing in health centres and health posts, and by low malaria transmission levels and 
reported fever.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Indonesia has a diverse malaria epidemiology and one 
of the highest burdens of malaria in Southeast Asia. The 
6000 inhabited islands, with a population of approxi-
mately 230 million people, have high heterogeneity 
of risk of infection, malaria incidence, and Anopheles 
distribution [1]. Five species of Plasmodium are present 
in Indonesia. The relative proportions of Plasmodium 
vivax cases as compared to Plasmodium falciparum has 
been increasing [2] and is of concern due to high-grade 
multidrug-resistance to P. vivax in Papua Province in 
particular [3, 4].
Malaria in pregnancy (MiP) has devastating conse-
quences for both the mother and the baby. In Indonesia 
in 2007, 6.4 million pregnancies occurred in areas with P. 
falciparum and/or P. vivax transmission [5]. The clinical 
Open Access
Malaria Journal
*Correspondence:  Jayne.Webster@lshtm.ac.uk 
1 Faculty of Infectious and Tropical Diseases, London School of Hygiene 
and Tropical Medicine, London, UK
Full list of author information is available at the end of the article
Page 2 of 13Webster et al. Malar J  (2018) 17:310 
effects of MiP depend upon the level of transmission, 
the malaria species and the level of immunity in preg-
nant women. Both P. falciparum and P. vivax contribute 
to the burden of MiP in Indonesia. Plasmodium falcipa-
rum malaria infections in pregnancy are associated with 
severe maternal anaemia, fetal loss and low birth weight 
(LBW), whilst P. vivax is associated with maternal anae-
mia, LBW and preterm births [6–8].
The Asia–Pacific region has no standardized and 
widely recognized strategy for prevention of MiP. In 
malaria endemic areas outside of sub-Saharan Africa, 
including the Asia–Pacific region, the strategy for MiP is 
the use of long-lasting insecticidal nets (LLINs) and pas-
sive case detection (PCD). In 2012 however, in malaria 
endemic areas Indonesia introduced single screening and 
treatment (SST) on first visit to antenatal clinic (ANC) 
followed by PCD at all subsequent visits [9], together 
with provision of an LLIN. The nationally recommended 
treatment for MiP in the 2nd and 3rd trimesters in Indo-
nesia is dihydroartemisinin-piperaquine (DHP) and qui-
nine in the first trimester when the study was conducted.
The heterogeneous nature of malaria epidemiology, 
co-existence of P. falciparum and P. vivax, together with 
socio-economic and cultural differences across different 
islands of Indonesia are likely to contribute to variations 
in the effectiveness of malaria control tools. In the case 
of SST, differences in levels of adherence to and imple-
mentation of the strategy between districts/provinces 
will also contribute to variations in its effectiveness. The 
aim of the study was to evaluate for the first time since its 
introduction, the implementation of SST for the control 
of malaria in pregnancy as per the national guidelines in 
two islands of Eastern Indonesia, Papua and Sumba.
Methods
Study site
The study was undertaken in Mimika District, Papua 
Province in Eastern Indonesia from February to August 
2013; and in West Sumba District, Sumba, in East Nusa 
Tenggara Province from June to November 2014. Papua 
is one of the seven main islands of Indonesia and Sumba 
is a small island, one of the Lesser Sunda islands. Mimika 
District has a population of 202,359 [10], which includes 
a diverse number of ethnic groups mainly due to eco-
nomic migration to Timika’s mining industry, and the 
National Transmigration Programme. West Sumba has a 
population of 121,901.
Malaria transmission in Papua is unstable and occurs 
mainly in the lowland areas, where the majority of the 
population live. Recent estimates of malaria prevalence in 
Papua for the general population are 12.2% [2] in 2016, 
and 16.8% for pregnant women at delivery [11], in 2008. 
Prevalence estimates are lower in Sumba at 6.8% in the 
wet season and 4.9% in the dry season in 2009 [12] in the 
general population, and 5.5% in pregnant women in 2005 
[13].
The topography of Mimika is such that not all areas of 
the sub-district, and therefore health centres, are read-
ily accessible. For example, some health centres take 
more than 2 days to reach by boat, and for others access 
requires chartering an aeroplane. Accessibility is not a 
problem in West Sumba with its landscape of low, lime-
stone hills.
Health system structure
The major structures for delivering health care are hos-
pitals, community health centres (puskesmas), sub health 
centres (pustus) and community integrated village health 
posts (posyandus). Health centres, are mainly located one 
per sub-district (serving a population of approximately 
30,000 people) and provide maternal and child care, fam-
ily planning and in-patient and outpatient services. Each 
health centre manages several health posts, and the num-
ber of health posts managed varies between health centres. 
The health posts provide maternity and child health ser-
vices, family planning, nutritional development, immu-
nization and diarrhoea control. The study was conducted 
in hospitals, health centres and health posts. Mimika has 
2 hospitals one of which is government run. There are 23 
health centres, 32 sub health centres, and 129 health posts. 
The district of West Sumba has 2 hospitals, one of which is 
government run, 9 health centres, and 75 health posts.
Study design
A mixed methods observational study was conducted 
using cross sectional surveys at hospitals, health centres 
and health posts in the two study sites at different time 
points. Observations and exit interviews of the ANC visit 
were conducted to assess compliance with national SST 
guidelines. The quantitative study was supplemented by 
in-depth interviews with health workers and focus group 
discussions with pregnant women accessing ANC to 
understand quantitative observations, these findings are 
reported elsewhere [14].
The intervention
Under the SST guidelines [9], all women on their first 
visit to ANC should be given a parasitological test for 
malaria either by microscopy or RDT, regardless of symp-
toms, together with an LLIN (Fig. 1). On the second and 
subsequent visits to ANC, pregnant women are tested for 
malaria only if they have symptoms of suspected malaria, 
that is PCD. Pregnant women should be treated with qui-
nine or an artemisinin combination therapy (ACT) DHP, 
depending upon their trimester, if they have a positive 
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parasitological test. Pregnant women who have a nega-
tive parasitological test for malaria, should not be given 
an anti-malarial.
Sample size
A sample size of 889 women was required for each of the 
study sites, based upon a conservative estimate of 50% of 
women reaching the SST endpoint (receiving the correct 
number of tablets of DHP), a design effect of 1.6 [15] and 
a standard error of 0.03 [16]. The sample size at each hos-
pital and health centre was proportional to the number of 
1st + 4th ANC visits in the previous year (2012 for Papua 
and 2013 for Sumba).
Selection of participants and data collection
In each study site the sampling units for the cross sec-
tional survey were the hospital and community health 
centres. The hospitals were purposively selected and 
a sampling frame of health centres constructed. Each 
health centre sampling unit included the health centre 
itself, together with the health posts under its manage-
ment. In Mimika, all health centres that were logistically 
feasible to reach were included in the sampling frame, 
and in West Sumba all health centres were included. 
According to routine health system data, the inaccessible 
health centres in Mimika had very low estimated popu-
lations of pregnant women in their catchment areas and 
were therefore not a significant sampling loss.
In Papua and Sumba, data on number of ANC visits 
(1st and 4th) are manually collected in paper format at 
both health centres and health posts. Numbers are then 
collated at the health centre and submitted to the health 
management information system (HMIS) as total num-
bers for the health centre and its associated health posts. 
Given this health system data collection procedure, it 
was not possible to disaggregate data on past ANC vis-
its by health centre and health post. ANC outreach at 
individual health posts was conducted once or twice per 
month, and sampling for the study was conducted based 
on the health post schedules, that is, the ones that were 
conducted during the time of the survey. Sampling was 
alternated daily between health centres and health posts, 
until the required sample size for each health centre and 
its associated health posts was reached.
Data collection instruments and procedures
Data collection instruments included a structured ques-
tionnaire for exit interviews with ANC attendees, a 
structured checklist for ANC observations, and a struc-
tured health facility audit. Field workers and supervisors 
were trained in data collection over a period of 6 weeks 
in Mimika and 3  weeks in West Sumba. The head of 
each health facility was approached and informed about 
the study, and their permission to conduct the study 
requested. Once the signed consent of the head of the 
health facility was gained, then other health workers 
were approached, informed about the study and signed 
consent to be observed in their delivery of services to 
pregnant women accessing ANC, sometime over the 
following few weeks. The health facility audit was con-
ducted by one of the fieldworker team supervisors, to 
collect information on numbers of women accessing 
ANC in the previous year, availability of microscopes and 
RDTs, and stocks of DHP.
No malaria
symptoms
First ANC visit
Malaria
symptoms
2+ ANC visit
Malaria
symptoms
No malaria
symptoms
Parasitological
test for malaria
Parasitological
test for malaria
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parasitological
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posive
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No ACT given
SCREENING
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Fig. 1 SST guideline overview
Page 4 of 13Webster et al. Malar J  (2018) 17:310 
Fieldworkers conducted the observations and inter-
views with ANC attendees by approaching a woman 
as she entered the health facility, they then introduced 
the study, gained the written consent of the woman, 
observed her ANC visit, and interviewed her on exit. 
On completion of the process with the first woman they 
then approached the next woman to enter the facility and 
repeated the process. During the ANC observations, the 
fieldworkers used the structured checklist to record what 
they saw and heard including verbal exchanges between 
the health worker and pregnant woman on illness and 
symptoms relating to malaria, conduct of a parasitologi-
cal test for malaria, referral for a parasitological test, and 
any drugs given by directly observed therapy, or to be 
taken at home. The exit interview included direct ques-
tions to the pregnant woman on her demographics, 
pregnancy history, previous attendance at ANC, events 
during the just completed ANC visit, examination of 
any drugs received for taking at home, and knowledge 
on how to take the drugs. Interviews were conducted in 
Bahasa Indonesia, the national language of Indonesia.
Data analysis
Definitions
Malaria test for the purposes of this analysis, having a 
malaria test was defined as having an RDT conducted, or 
a slide prepared for malaria microscopy. Data from obser-
vations.
Screening was defined as having a malaria test at a first 
ANC visit. Data from observations.
Passive case detection a malaria test in women with sus-
pected malaria. Data from observations.
Suspected malaria suspected malaria was defined as 
fever reported by the health worker or the pregnant 
woman [17]. Data from observations.
Malaria symptoms malaria symptoms were defined as 
headache, general pain, general weakness, flu, nausea, 
vomiting or dizziness. Data from observations.
Data were double entered and validated using Epi-
Data version 3.1, Stata 14.0 was then used for data pro-
cessing and analysis. Analyses accounted for the survey 
design, adjusting for clustering within health facilities. 
The cross-sectional survey was based on a single visit 
to ANC by a pregnant woman and the unit of analy-
sis was therefore a woman’s ANC visit. Prevalence of 
malaria symptoms at first and 2nd and above (2+) visits 
to ANC were described. A systems effectiveness analy-
sis [18] was undertaken comprising an assessment of the 
effectiveness of individual intermediate processes in SST 
and cumulative overall effectiveness of SST for first ANC 
and second and above ANC visits by pregnant women 
based on Fig.  1. The effectiveness of each intermediate 
process in the delivery system effectiveness algorithm 
was calculated by estimating the proportion of women 
who successfully reached each step from the previous 
step [19, 20].
Principal components analysis (PCA) was used to cre-
ate an asset index [21] based upon household charac-
teristics including drinking bottled water, having a flush 
toilet, having no toilet facilities, cooking on wood, hav-
ing: cement floors, solar power, a radio, a television, a 
mobile telephone, a landline, a fridge, a bike, a motorbike, 
a car, and a boat. All assets were included in the PCA 
as binary variables [22]. The asset index was then used 
to construct socio-economic quintiles from the poorest 
households through to the least poor. In this study, these 
socio-economic quintiles were not representative of the 
population level, but are a relative score amongst women 
who attend ANC in each site.
Univariate (unadjusted) logistic regression was used 
to test for an association between being screened for 
malaria on 1st visit to ANC and socio-demographic, 
pregnancy related factors and suspected malaria, includ-
ing trimester, gravidity, age, marital status, level of educa-
tion, religion, level of facility at which the visit to ANC 
was made, socio-economic quintile, and reported fever. 
Any factors with an odds ratio (OR) significant at the 
10% level (p-value < 0.1) were included in multi-variable 
(adjusted) logistic regression model to determine which 
potential predictors of having a malaria test on first visit 
to ANC, were associated when adjusted for other predic-
tors. In the multivariable model, predictors were con-
sidered significant at the 10% level at all stages of model 
building except for the final model where p < 0.05 was 
used.
Ethics
Consent for the study was obtained from the Institutional 
Review Board and Research Ethics Committees (REC) at 
the Eijkman Institute for Molecular Biology, Indonesia, 
and the Liverpool School of Tropical Medicine (LSTM). 
Endorsement was obtained from the Litbanges (NIH), 
Ministry of Health, Indonesia and deferral to the LSTM 
REC by the ethics committee of the London School of 
Hygiene and Tropical Medicine.
Results
A total of 865 and 895 ANC visits in Mimika and West 
Sumba were included in the study across 7 and 10 health 
facilities, respectively (Table  1). In Mimika, 28.2% of 
the visits were to hospitals, 48.9% to health centres, and 
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35.9% to health posts; in Sumba, the distribution of ANC 
visits sampled was 17.1% to hospitals, 39.2% to health 
centres and 60.8% to health posts. The sampling distribu-
tion in Mimika, based on proportions of 1st and 4th vis-
its during the previous year, was highly focussed in two 
health centres, with one of these and its managed health 
posts comprising 36.1% of the overall sample. In West 
Sumba, except for one health centre and its health posts 
that formed 29.2% of the overall sample, ANC visits sam-
pled across health facilities were more evenly spread.
Health centres in the districts studied in both sites 
were managing a median of 10 and 12 health posts, 
ranging from 5 to 22 in Mimika and 2 to 19 in West 
Sumba. In the year previous to the surveys (2012 for 
Mimika and 2013 for West Sumba), numbers of new 
ANC clients were higher in hospitals of Mimika than in 
West Sumba (1280 and 286, respectively), median num-
bers for health centres and their managed health posts 
were similar, but with a skew towards two larger health 
centres in Mimika. Four health centres had a medical 
doctor in Mimika, whereas none of the health centres 
had medical doctors in West Sumba. Numbers of mid-
wives varied from 13 in the larger health centre in Mim-
ika to none in a relatively small health centre in West 
Sumba. All except 1 health centre in Mimika had 1–2 
functioning microscopes. Only 2 of the 6 (33%) health 
centres in Mimika had received RDTs in the previous 
6  months (prior to the study date), had RDTs at the 
time of the survey and reported that they used RDTs in 
ANC. In West Sumba, 2 of the 9 (22%) health centres 
had received RDTs in the previous 6  months and had 
them at the time of the survey; none of the health cen-
tres reported using RDTs in ANC. Equipment for ANC, 
including RDTs when available, was taken on outreach 
days from the health centres to the health posts, and 
therefore at the time of the study lack of RDTs in the 
health centres meant that the majority of health posts 
in both sites did not have access to RDTs. In Mimika, 
2 health centres reported that their health posts per-
form RDTs, 2 that their health posts make slides and 
send them to the health centre and 2 that their health 
posts refer women elsewhere for malaria tests. In West 
Sumba, none of the health centres reported that their 
health posts perform RDTs, one health centre said that 
their health posts make slides and send to the health 
centre, and others that they refer women elsewhere for 
malaria parasite tests.
The characteristics of pregnant women sampled in 
both sites were similar, approximately 50% were in the 
second trimester, 50% had already given birth twice or 
more, approximately 60% were 20–29  years of age, and 
the majority were married (Table 2). Numbers of visits to 
ANC were high, with the current visit for nearly 50% of 
women in both sites being their 4th or more visit.
Prevalence of fever was similar across both study sites 
at 3.2% (95% CI 1.1, 9.1) in Mimika and 2.8% (95% CI 1.1, 
6.7) in West Sumba (Table 3). Prevalence of other poten-
tial symptoms of malaria was also similar across study sites 
with nausea, vomiting and dizziness being the most preva-
lent. Nausea, vomiting and dizziness were more prevalent 
in women on their first visit to ANC than on 2+ visits.
SST intermediate systems effectiveness at first ANC visit
A total of 346 first ANC visits were observed, 185 in 
Mimika and 161 in West Sumba. Amongst the women 
attending hospitals for ANC only small proportion were 
first visits, 13.4% in Mimika and 5.9% in West Sumba. 
First visits formed a higher proportion of overall visits 
in health posts in Mimika 28.8% (95% CI 18.2, 42.2) and 
health centres 25.3% (95% CI 18.2, 33.9) in West Sumba.
Malaria screening at first ANC visit among pregnant 
women was 51.4% (95% CI 11.9, 89.2) in health facilities 
Table 1 Sampled ANC attendees in Mimika and West Sumba
Mimika West Sumba
Facility Hospital Health centre Health post Total Facility Hospital Health centre Health post Total
Mimka 1 216 216 Sumba 1 153 153
Mimka 2 192 184 376 Sumba 2 2 62 64
Mimika 3 149 5 154 Sumba 3 5 42 47
Mimika 4 28 0 28 Sumba 4 44 217 261
Mimika 5 4 52 56 Sumba 5 29 24 53
Mimika 6 0 34 34 Sumba 6 61 34 95
Mimka 7 1 0 1 Sumba 7 10 39 49
Sumba 8 37 2 39
Sumba 9 8 80 88
Sumba 10 2 44 46
Total 216 374 275 865 153 351 544 895
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in Mimika and 24.8% (95% CI 10.3, 48.9) in West Sumba 
(Table 4). Adherence to first ANC visit screening varied 
by level of health facility and was high at 94.8% (95% CI 
81.1, 98.7) in health centres of Mimika (Table 5). Two-
thirds of first ANC visits were screened in the hospital 
in Mimika compared with 0% in West Sumba. Imple-
mentation of screening for malaria in health posts of 
both sites was poor, with less than 10% of first ANC 
visits screened. Most screening conducted at first ANC 
visit in both sites was by microscopy. In Mimika, 1.1% 
(2/185) first ANC visits were screened by RDT, and in 
West Sumba 1.2% (2/161). All four RDTs conducted on 
first ANC visit were performed at health posts.
In Mimika, 18/95 (3.5%) first ANC visits that were 
screened had a positive malaria test, 2 at the hospital, 15 
at a health centre, and 1 at a health post. This equates to 
a positivity rate of 18.9%. Amongst those first ANC vis-
its testing positive, 11 (61.0%) were given DHP, 10 of the 
Table 2 Characteristics of sampled ANC attendees in Mimika and West Sumba
Mimika West Sumba
N % 95% CI N % 95% CI
Trimester
 1st trimester 138 16.0 12.8, 19.8 140 15.7 12.5, 19.5
 2nd trimester 436 50.5 36.4, 64.4 485 54.3 44.9, 63.2
 3rd trimester 290 33.6 19.6, 51.1 268 30.0 20.8, 41.3
Gravidity
 Gravida 1 249 28.8 24.6, 33.5 270 30.4 24.9, 36.5
 Gravida 2 256 29.6 26.5, 33.0 207 23.3 19.8, 27.2
 Gravida ≥ 3 359 41.6 35.7, 47.7 411 46.3 42.2, 50.5
Age group
 12–19 70 8.1 6.3, 10.4 57 6.4 4.0, 10.1
 20–29 536 62.0 54.6, 68.8 507 56.7 50.6, 62.6
 30–39 242 28.0 20.7, 36.7 292 32.6 28.1, 37.5
 ≥ 40 17 2.0 1.0, 3.7 39 4.4 2.7, 7.1
Marital status
 Single 141 16.3 13.9, 19.0 48 5.4 4.1, 7.0
 Married 722 83.5 80.9, 85.7 845 94.4 92.6, 95.8
 Divorced 2 0.2 0.0, 1.8 2 0.2 0.1, 0.8
 Widowed 0 0 0 0 0 0
Education
 Not attended school 39 4.5 1.2, 15.5 87 9.7 4.9, 18.5
 None completed 10 1.2 0.4, 3.4 89 9.9 6.9, 14.2
 Primary 120 13.9 10.2, 18.6 232 25.9 17.6, 36.4
 Secondary 189 21.9 18.0, 26.4 162 18.1 14.5, 22.4
 Post-secondary/technical 419 48.5 43.1, 53.9 249 27.8 22.0, 34.5
 Tertiary 87 10.1 6.6, 15.0 76 8.5 2.3, 26.7
Religion
 Catholic 171 19.8 16.2, 23.9 166 20.9 15.4, 27.7
 Protestant 370 42.8 32.1, 54.2 610 76.7 69.8, 82.5
 Muslim 324 37.5 28.9, 46.9 19 2.4 0.7, 8.1
ANC Visit number
 1 185 21.4 13.4 161 18.0 12.7, 24.8
 2 145 16.8 14.1, 19.9 169 18.9 14.9, 23.7
 3 132 15.3 12.8, 18.2 138 15.4 13.1, 18.0
 4+ 403 46.6 33.7, 60.0 427 47.7 38.1, 57.5
First ANC visit
 Hospital 29 13.4 – 9 5.9 –
 Health centre 77 20.5 12.3, 32.3 50 25.3 18.2, 33.9
 Health post 79 28.8 18.2, 42.4 102 18.8 14.5, 23.9
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women given DHP were in the second trimester of their 
pregnancy and one was in the first trimester. Of the five 
women positive for malaria was given quinine, four were 
in their first trimester of pregnancy and one was in the 
second trimester. In West Sumba, only one woman on 
her first ANC visit tested positive for malaria (by micros-
copy) in a health centre. The pregnant woman was symp-
tomatic for malaria and was given DHP. Therefore, the 
intermediate process effectiveness for those screened 
for malaria, i.e., those positive were given DHP or qui-
nine as appropriate for their trimester, and those that 
were negative were not given DHP or quinine, was 92.6%. 
Adherence to treatment guidelines based on malaria test 
results was high.
No women on their first visit to ANC in Mimika or 
West Sumba, who were either screened negative for 
malaria parasites or not tested, were given DHP.
SST intermediate process effectiveness at second 
or above ANC visits
A total of 1414 women on their second or above visits 
to ANC were sampled, 680 in Mimika and 734 in West 
Table 3 Prevalence of malaria symptoms in Mimika and West Sumba on 1st and 2nd or above visit to ANC
Symptom Mimika prevalence West Sumba prevalence
1st ANC 2+ ANC 1st ANC 2+ ANC
n % 95% CI n % 95% CI n % 95% CI n % 95% CI
Fever 6 3.2 1.1, 9.1 19 2.8 1.1, 6.7 7 4.3 1.6, 7.4 26 3.5 1.7, 7.4
Headache 7 3.8 2.0, 7.1 15 2.2 1.3, 3.6 7 4.3 1.6, 11.5 38 5.2 2.8, 9.3
General pain 9 4.9 2.2, 10.2 49 7.2 4.4, 10.2 11 6.8 3.9, 11.8 76 10.4 7.7, 13.8
General weakness 4 2.2 0.7, 6.2 4 0.6 0.3, 1.3 14 8.7 4.2, 17.1 27 3.7 1.8, 7.5
Flu 2 1.1 0.2, 6.0 15 2.2 1.3, 3.7 6 3.7 1.5, 9.1 25 3.4 1.6, 7.2
Nausea 44 23.8 17.4, 31.6 42 6.2 4.1,9.2 37 23.0 15.9, 32.1 52 7.1 5.5, 9.2
Vomiting 26 14.1 11.1,17.7 28 4.1 1.9, 8.5 23 14.3 7.2, 26.4 24 3.3 1.7, 6.0
Dizzy 28 15.1 10.4, 21.5 48 7.1 5.5, 9.1 46 28.6 21.7, 36.7 114 15.5 10.9, 21.6
Table 4 Individual and cumulative systems effectiveness for SST in Mimika and West Sumba
Mimika West Sumba
n Process 
effectiveness
Cumulative 
effectiveness
n Process 
effectiveness
Cumulative 
effectiveness
1st ANC visit 185 100 100 161 100 100
 Screened for malaria 95 51.4 51.4 40 24.8 24.8
 Positive 18 18.9 9.7 1 2.5 0.1
 Positive given ACT or quinine 14 77.8 7.6 1 100 0.1
≥ 2nd ACT visit 680 100 100 734 100 100
 Reported fever 19 2.8 2.8 26 3.5 3.5
 Screened for malaria if reported fever 17 89.5 2.5 12 46.2 1.6
 Positive 7 41.2 1.0 0 0 0
 Positive given ACT 5 71.4 0.7 0 0 0
Table 5 Malaria parasite screening at 1st ANC visit by level of health facility
Mimika West Sumba
n % 95% CI n % 95% CI
Hospital 19 65.5 – 0 0
Health centre 73 94.8 81.1, 98.7 30 60.0 32.6, 82.3
Health post 3 3.8 1.6, 8.8 10 9.8 4.4, 20.5
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Sumba. Amongst women attending hospitals for ANC 
a high proportion were second or above visits: 86.6% in 
Mimika and 94% in West Sumba. Second or above vis-
its formed approximately 70% to 80% of all ANC visits 
to health centres and health posts in Mimika and West 
Sumba, respectively.
Reported fever was low amongst pregnant women on 
their second or above visit to ANC, 2.8% (95% CI 1.1, 6.7) 
in Mimika and 3.5% (95% CI 1.7, 7.4) in West Sumba. Of 
those women on their second or above visit to ANC with 
reported fever, 89.5% (95% CI 59.7, 98.0) in Mimika and 
46.2% (95% CI 15.7, 79.8) in West Sumba were tested for 
malaria.
In Mimika amongst pregnant women on their second 
or above visit to ANC who had suspected malaria and 
were tested, 7 tested malaria positive, and 10 tested nega-
tive. Of those positive for malaria, 5 were given DHP and 
1 was given quinine and amongst those negative, none 
were given DHP or quinine. This translates to 85.7% of 
women tested for malaria on a second or above visit to 
ANC being treated as per the national guidelines. In 
West Sumba none of the 12 women with reported fever 
who were screened for malaria were positive and none 
were given DHP or quinine.
Cumulative systems effectiveness
Cumulative systems effectiveness for SST on first visit 
to ANC was 7.6% for Mimika and 0.1% for West Sumba 
(Fig. 2); and for second or above visits to ANC was 0.7% 
in Mimika and 0% in West Sumba.
Predictors of being screened for malaria on first visit 
to ANC
In Mimika, there was no association in univariate 
analyses between having a malaria test on first visit to 
ANC and any of the tested socio-demographic factors, 
pregnancy related factors, or reported fever  (Table  6). 
Level of health facility was the only predictor of being 
screened for malaria on a 1st visit to ANC: refer-
ence: health centres OR 1.0; health post OR 0.002 (95% 
CI 0.0004, 0.01; hospital OR 0.1 (95% CI 0.02, 0.4); 
p = 0.0001 (Table 5). In West Sumba, predictors of having 
a malaria test at 1st visit to ANC in the univariate analy-
ses included trimester, age, level of education, level of 
health facility and reported fever, but in the multi-varia-
ble model the only predictor was level of facility AOR 0.2 
(95% CI 0.03, 0.8) p = 0.03; with reported fever dropped 
from the model because reported fever perfectly pre-
dicted having a malaria test.
Discussion
In this study, the implementation of SST for malaria in 
pregnant women per national guidelines in two districts 
of Indonesia with different levels of malaria transmission 
was evaluated. Indonesia has a policy of SST for malaria 
in pregnancy in all areas of malaria transmission, and is 
one of the few countries in the Asia–Pacific Region with 
a specific malaria in pregnancy control policy, in addition 
to the distribution of LLINs. The evaluation in Mimika 
was approximately 2  years post policy adoption by the 
Ministry of Health, and in West Sumba approximately 
3 years post policy.
Systems effectiveness was used to assess the propor-
tion of pregnant women accessing ANC for first or 
second and above visits who received overall malaria 
prevention as defined by the national policy of SST, and 
who completed the individual intermediate processes 
comprising SST. Systems effectiveness has been used to 
assess implementation of malaria control interventions 
including case management, delivery of intermittent 
preventive treatment in pregnancy and delivery of long 
lasting insecticidal nets (LLINs) [18, 19, 23]. No studies 
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Fig. 2 SST cumulative systems effectiveness for 1st (malaria screening) and ≥ 2nd visits (passive case detection) to ANC in Mimika and West Sumba
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Table 6 Predictors of being screened for malaria parasites at 1st ANC visit
Italic values indicate significance of p value (OR p < 0.1; AOR p < 0.05)
* Reported fever perfectly predicted having a malaria test
Mimika West Sumba p
Unadjusted n Unadjusted p Adjusted
n OR (95% CI) p OR (95% CI) AOR (95% CI)
Trimester
 1st 37 1.0 0.2 23 1.0 0.02 1.0 0.5
 2nd 54 1.2 (0.7, 2.3) 15 0.5 (0.4, 0.8) 0.7 (0.3, 1.9)
 3rd 3 0.4 (0.1, 6.2) 1 0.6 (0.1, 3.5) 1.0
Gravidity
 0 32 1.0 0.2 14 1.0 0.1
 1 26 1.1 (0.6, 2.0) 11 0.5 (0.2, 1.6)
 ≥ 2 37 0.6 (0.4, 1.1) 15 0.3 (0.1, 0.9)
Age
 12–19 12 1.0 0.2 7 1.0 0.002 1.0 0.9
 20–29 58 0.8 (0.4, 1.5) 25 0.4 (0.1, 1.6) 0.9 (0.3, 2.7)
 30–39 22 0.5 (0.2, 1.0) 6 0.1 (0.05, 0.4) 0.7 (0.2, 2.9)
 40+ 3 – 2 0.4 (0.04, 3.8) 1.0
Marital status
 Single 23 1.0 0.3 2 1.0 0.7
 Married 72 0.7 (0.3, 1.6) 38 1.3 (0.3,7.2)
 Widowed 0 0 0 0
Education
 None 4 1.0 0.2 5 1.0 0.001 1.0 0.9
 None completed 1 0.3 (0.01, 1.4) 1 0.2 (0.01,2.2) –
 Primary 16 0.8 (0.01, 57.9) 12 1.0 (0.2, 5.5) 0.7 (0.2, 2.1)
 Secondary 17 0.3 (0.01, 17.1) 10 1.7 (0.3, 9.6) 1.0 (0.2, 2.3)
 Post-secondary 49 0.6 (0.01, 30.5) 11 2.1 (0.5, 8.4) 1.6 (0.3, 8.6)
 Tertiary 8 0.7 (0.02, 20.1) 1 0.7 (0.03,13.5) 1.2 (0.006, 239.9)
Religion
 Catholic 15 1.0 0.3 6 1.0 0.5
 Protestant 47 2.2 (0.8, 6.3) 30 1.5 (0.4, 5.3)
 Islam 33 1.5 (0.6, 3.6) 0 –
Level of facility
 Health centre 1.0 0.0001 30 1.0 0.002 1.0 0.03
 Health post 3 0.002 (0.0004, 0.01) 10 0.07 (0.02, 0.3) 0.2 (0.03,0.8)
 Hospital 19 0.1 (0.02, 0.4) 0 – –
Socio-economic quintile
 Poorest 18 1.0 0.5 5 1.0 0.1
 Very poor 20 1.5 (0.3, 6.9) 10 1.6 (0.3, 8.8)
 Poor 18 1.3 (0.3, 5.8) 12 2.7 (0.6, 11.6)
 Less poor 23 1.5 (0.4, 6.3) 9 2.7 (0.5, 16.5)
 Least poor 16 2.1 (0.5, 9.1) 4 2.3 (0.1, 38.8)
Reported fever
 No 41 1.0 0.2 30 1.0 0.05 –*
 Yes 5 5.0 (0.3, 96.5) 6 11.4 (1.1, 121.5) –*
Page 10 of 13Webster et al. Malar J  (2018) 17:310 
of systems effectiveness for evaluating implementation of 
screening and treatment of malaria control interventions 
were available for comparison of outcomes.
Being screened for malaria on the first visit to ANC 
was associated with level of facility in Mimika and West 
Sumba, and with reported fever in West Sumba. In both 
study sites adherence to malaria screening on first visit 
to ANC were more likely to take place if the woman 
attended a health centre, testing was unlikely at health 
posts in both sites and was not given to any of the women 
sampled at the hospital in Sumba. The lack of associa-
tion between having a malaria test and reported fever, 
together with the high proportion of women having a 
malaria test when attending health centres of Mimika, 
represents adherence to this element of the strategy. This 
was not the case in Sumba where only a small proportion 
of women were given a malaria test on their first ANC 
visit and this was associated with reported fever. As there 
are no published studies of this strategy, it is not possi-
ble to draw comparisons on its implementation in other 
countries.
Screening for malaria parasites was implemented only 
where microscopy was available. The use of RDTs for 
screening for malaria in pregnant women was not imple-
mented in either study site, including at health posts 
where microscopy was not available. During some ANC 
visits at health posts, pregnant women had blood taken 
and a microscope slide prepared, but this was not com-
mon practice. It is not possible to draw on routine data 
to estimate the proportion of first ANC visits that take 
place in health posts relative to other levels of health 
facility, because health centre and health post data are 
merged before inclusion in the health management infor-
mation system. However, in this study amongst those 
attending health posts 29% were first ANC visit in Mim-
ika, and 19% in West Sumba. It is therefore important 
that either RDTs are deployed and used in health posts, 
or slides for malaria microscopy are taken from all first 
ANC visit women attending health posts. The second of 
these options is potentially less likely to be successfully 
implemented as it would require pregnant women to 
then attend the health centre for their results, and anti-
malarials as required.
In Mimika, approximately two-thirds (64%) of first 
ANC visit women screened positive for malaria did 
not report fever, nor was fever suspected by the health 
worker. In the absence of screening, these women would 
not have been diagnosed for malaria. Sub-microscopic 
infections and asymptomatic infections have previ-
ously been identified in Papua [2, 24], yet the associated 
clinical outcomes of these infection are not well under-
stood. In an observational study of ANC visits in east-
ern India, blood tests were typically obtained if a patient 
complained of fever, though enquiries into presence of 
fever in patients were made in only a minority of patients 
[25]. In Mimika, based on the study findings of malaria 
parasite prevalence compared to the prevalence of fever, 
parasite positive women would be missed if tested only 
based on the presence of symptoms.
Adherence to guidelines on treating malaria positive 
women with the nationally recommended drugs was 
high. In Mimika approximately 90% of first ANC visit 
women testing positive for malaria were treated with 
DHP or quinine. The drug they were given was associated 
with trimester, with the majority of first trimester women 
being given quinine and second trimester DHP. There 
were no cases of pregnant women being given a course 
of treatment with DHP without being tested, and found 
positive.
The malaria parasite prevalence in 1st visit ANC 
attendees in Mimika at 18.9% was slightly higher than 
that reported in 2008 for women at delivery in the same 
study site [11]. In West Sumba, it was not possible to esti-
mate malaria parasite prevalence, as having a malaria test 
was associated with being febrile and therefore a case 
of suspected malaria. Prevalence of reported fever was 
lower than parasite prevalence in Mimika, that is malaria 
was asymptomatic in some pregnant women, and was 
similar in both sites at approximately 3% amongst 1st and 
second and above visit ANC attendees. Reported fever 
was not validated by recording temperature.
Passive case detection requires that women with sus-
pected malaria are tested for malaria parasites and 
treated with DHP if positive. Clinical symptoms of 
malaria in pregnancy beyond fever, are very ill-defined, 
but are known to vary depending upon level of malaria 
transmission and the woman’s immunological response. 
Whilst the WHO recommendation is that any woman 
with a fever be treated as a suspected malaria case, it 
is likely that this overestimates the number of cases, as 
has been shown in sub-Saharan Africa [26]. There is a 
dearth of data on implementation of PCD for malaria in 
pregnancy in terms of clinical signs and symptoms that 
prompt health workers to suspect malaria, and request 
a parasitological test, and further the clinical symptoms 
that predict a positive parasitological test. Based on the 
association between symptoms and performing a malaria 
test in Mimika on 2+ visits, health workers view fever, 
vomiting and dizziness as potential symptoms of malaria, 
and in Sumba fever and general pain.
Despite the relative effectiveness of some individual pro-
cesses in delivery of SST to first, and second and above, 
ANC visit pregnant women, the cumulative effectiveness 
was low. The cumulative effectiveness starting point was 
the visit to ANC and the endpoint was the receipt of DHP 
or quinine. In this study, the cumulative effectiveness 
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was dependent upon the decisions made by ANC health 
workers, whether to screen on first visit or test on second 
and above, and their access to malaria tests; but also on 
malaria transmission, being positive for malaria when 
screened, and being reported with suspected malaria, i.e., 
febrile on a second or above visit to ANC.
Systems effectiveness analyses in malaria control have 
varied in their starting points including accessing ANC 
[19, 23], being pregnant [27], and people or children 
with current or recent fever [27], and in the processes 
included. For some, all those included at step one should 
be eligible for each subsequent process as for example in 
the delivery of IPTp [23], whereas others including case 
management will only be eligible for treatment depend-
ing upon a positive malaria test [28].
The study was undertaken pre-implementation of a 
cluster randomized controlled superiority trial of the 
current policy of SSTp-DHP versus two alternative strat-
egies which were intermittent screening and treatment 
(ISTp-DHP) and IPTp-DHP. The trial hypothesis was that 
among pregnant women protected with LLINs, inter-
mittent screening with RDTs at ANC visits provided 
monthly during pregnancy and treatment of RDT posi-
tive women with DHP (ISTp-DHP), or IPTp with DHP 
(IPTp-DHP) is more efficacious than SST (SSTp-DHP) in 
preventing malaria in pregnancy in an area of relatively 
low prevalence of P. falciparum and P. vivax.
Findings of this current observational study supple-
ment the trial findings in taking forward a strategy for 
malaria prevention in Eastern Indonesia. For either 
SSTp-DHP or ISTp-DHP to be effectively implemented, 
malaria tests and drugs need to be introduced and sus-
tained at all health posts either by RDTs or by taking a 
microscope slide for malaria to be tested at the health 
centre. The use of RDTs would be preferable as this is 
more likely to result in the woman being tested and 
treated, than the relatively complex system of ensuring 
that the result is received by the woman and treatment 
dispensed appropriately. A cost effectiveness study would 
be an important next step, but given the low level of sys-
tems effectiveness it is unlikely that SST would be cost 
effective in this setting.
Given the level of sub-microscopic malaria it is logi-
cal to hypothesize that IPTp-DHP would be superior 
to ISTp-DHP in Mimika. Should this be the case, much 
work will be needed to convince health workers, particu-
larly in health centres, that malaria tests are not needed 
when they are currently adhering so well to screening 
at first ANC visit. Conversely, in health posts, where 
malaria testing is not currently implemented, the accept-
ance of IPTp-DHP is likely to be relatively straight for-
ward. The adherence to the SSTp-DHP strategy may 
however indicate a general propensity to adhere to guide-
lines and, therefore, implementation of IPTp-DHP too, 
may be potentially successful. The qualitative study con-
ducted alongside this evaluation explores further the per-
ceptions of health workers on these strategies [14].
The study design had several limitations. Longitudinal 
following of women through their pregnancy to capture 
all visits to ANC was not included and the findings are 
therefore only a snapshot of individual visits to ANC. 
Due to the inaccessibility of some areas of the sub-dis-
trict and its health facilities in Mimika it was not possible 
to select samples from a sampling frame of all health cen-
tres. The unavailability of data distinguishing ANC visits 
at health centres versus health posts meant that it also 
was not possible to select samples stratified by these lev-
els of health facility. The process for enrolling pregnant 
women at each health facility was based upon implemen-
tation feasibility and was not technically random. There 
may have been a bias towards women attending at par-
ticular times of day and being given a parasitological test, 
however in Mimika and West Sumba approximately 95% 
and 93%, of women, respectively, began their ANC con-
sultation before 10 a.m.
Non-participant structured observations together 
with exit interviews were the main tool for assess-
ing the implementation of SST. It is possible that the 
health workers and the pregnant women changed their 
behaviours because they were being observed, this phe-
nomenon is called the Hawthorne effect [29, 30]. It was 
assumed that the participants exhibited their best behav-
iours at the time of being observed. It has been shown, 
that participants tend to revert to their normal practices 
after a small number of observations [30]. The behaviour 
of health workers was, therefore, likely to be normalized 
during the study, but not that of pregnant women.
Conclusion
Adherence to guidelines on SST for malaria prevention 
differed across the components of the strategy, across 
study sites, and by level of health facility within both 
Mimka and West Sumba. Cumulative effectiveness of 
SST for women on their first visit and women on their 
second or above visits was low. Screening and test-
ing was almost exclusively by microscopy. In Mimika, 
the high proportion of women screened positive for 
malaria who were asymptomatic means that passive 
case detection is not effective in detecting malaria in 
this setting. Generally, the treatment component of 
SST was adhered to with malaria positive women in 
first trimester given quinine, second/third trimester 
given DHP, and women not tested positive for malaria 
not treated.
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